Evotec SE Reports Results for the First Half-year 2022 and Provides Corporate Updates
BASE BUSINESS, NEW AND EXTENDED ALLIANCES DRIVE 24% GROWTHJUST - EVOTEC BIOLOGICS IN BUILD-UP PHASE - INVESTMENT ON TRACKACQUISITION EXPANDS CAPABILITIES AND EXPERTISE IN CELL THERAPYGUIDANCE FOR FULL-YEAR
Source: finanznachrichten.de